Methods for the treatment of tinnitus induced by cochlear excitotoxicity

a cochlear excitotoxicity and tinnitus technology, applied in the direction of biocide, heterocyclic compound active ingredients, drug compositions, etc., can solve the problems of inability to truly effective treat the disease, damage to the target neuron, and may eventually die, so as to prevent and/or treat tinnitus, suppress or reduce the aberrant activity of the nmda receptor of the auditory nerve, and prevent the effect of tinnitus

a cochlear excitotoxicity and tinnitus technology, applied in the direction of biocide, heterocyclic compound active ingredients, drug compositions, etc., can solve the problems of inability to truly effective treat the disease, damage to the target neuron, and may eventually die, so as to prevent and/or treat tinnitus, suppress or reduce the aberrant activity of the nmda receptor of the auditory nerve, and prevent the effect of tinnitus

US20060063802A1Inactive Publication Date: 2006-03-23INST NAT DE LA SANTE & DE LA RECHERCHE MEDICALE (INSERM) +1

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Methods for the treatment of tinnitus induced by cochlear excitotoxicity
  • Methods for the treatment of tinnitus induced by cochlear excitotoxicity
  • Methods for the treatment of tinnitus induced by cochlear excitotoxicity

Examples

Experimental program
Comparison scheme
Effect test

example 1

Methods and Materials

[0049] We developed and tested an animal model of tinnitus induced by cochlear excitotoxicity, which was provoked by acoustic trauma. As tinnitus in general is not directly observable, as cochlear excitotoxicity does not result in tinnitus in all individuals, and as perceptions of tinnitus may just disappear a few hours after the excitotoxic incident or last forever, the definition and implementation of such an animal model represented a substantial challenge. These considerations mean for example that more animals are required to obtain a sufficient number of tinnitus cases for study and to permit observation of tinnitus over time. As it is unclear whether a case of tinnitus induced by cochlear excitotoxicity is to last or not, it is advisable to conduct studies in its early stages.

[0050] The experiments were performed in two stages. First, the hearing loss following acute acoustic trauma as well as the incidence of tinnitus were evaluated with no therapeuti...

example 2

Methods and Materials

[0066] To evaluate the different mechanisms of salicylate and excitotoxicity induced tinnitus, comparative morphological analysis of the cochlear sensorineural structures as well as Western blot immunodetection following the two different types of tinnitus inducing incidents were performed.

Morphology

[0067] Two groups of 3 Long Evans rats each were either treated twice a day with an intraperitoneal injection of 350 mg / kg of sodium salicylate for 2 days or traumatized as described in [0036]. After decapitation of the rats under deep anaesthesia (pentobarbital 50 mg / kg), the cochleas were removed from the temporal bone and perfused with a fixative solution of 2.5% glutaraldehyde in 0.1 M phosphate-buffered saline (PBS), pH 7.3. They were then processed either for scanning (SEM) or transmission electron (TEM) microscopy. For SEM, the otic capsule was dissected out and the stria vascularis, tectorial, and Reissner's membranes were removed. After rinsing in PBS (...

example 3

Methods and Materials

[0074] In order to confirm and extend the results obtained in the previous experiments, we developed and tested another animal model of tinnitus induced by cochlear excitotoxicity, which allowed direct measurement of the presence of tinnitus, i.e. without using a behavioural model. Martin et al., Proceedings of the Fifth International Tinnitus Seminar, American Tinnitus Association: 127-134 (1996) described a narrow spectral peak at approximately 200 Hz in the spectrum of the ensemble spontaneous activity (β€œESA”) of the cochlear nerve in persons suffering from tinnitus. These results were consistent with findings in various animal models of from tinnitus. These results were consistent with findings in various animal models of tinnitus, suggesting that this peak was indeed an objective correlate of tinnitus. There has been, however, no specific objective evaluation of tinnitus induced by cochlear excitotoxicity, neither in human beings, nor in animals.

[0075] W...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
sound pressure levelaaaaaaaaaa
frequencyaaaaaaaaaa
pHaaaaaaaaaa
Login to View More

Abstract

The invention relates to methods for the prevention and / or treatment of tinnitus induced by cochlear excitotoxicity. In these methods, a pharmaceutical composition comprising an NMDA receptor antagonist is administered to an individual in need of such treatment by appropriate devices and / or formulations for local administration to the inner ear. The tinnitus to be prevented and / or treated may be provoked by acoustic trauma, presbycusis, ischemia, anoxia, treatment with one or more ototoxic medications, sudden deafness, or other cochlear excitotoxic-inducing occurrence. The invention also relates to method for the identification of compounds effective in the treatment and prevention of tinnitus by a novel screening method incorporating an electrophysiological test method.

Description

BACKGROUND OF THE INVENTION [0001] 1. Field of the Invention [0002] This invention relates to methods for the delivery of pharmaceutical compounds to the inner ear for the treatment of tinnitus induced by cochlear excitotoxicity. Specifically, this invention relates to the local administration of N-Methyl-D-Aspartate (NMDA) receptor antagonists to the inner ear to suppress the NMDA receptor mediated aberrant activity of the auditory nerve following acute, repeated or prolonged or chronic occurrences of cochlear excitotoxicity provoked by incidents such as acoustic trauma, presbycusis, ischemia, anoxia, treatment with one or more certain ototoxic medications or sudden deafness and thus, block tinnitus in the case of such incidents. [0003] 2. Description of Related Art [0004] Tinnitus, the perception of sound without external acoustic stimulation, is a very common inner ear disorder. It is estimated that 8.6 million Americans, about 3 percent of the U.S. population, suffer from chroni...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
23 Mar 2006
Publication
US20060063802A1
IPC
A61K31/4704; A61K31/495; A61K31/00; A61K31/135; A61K31/439; A61K31/4535; A61K31/517; A61K31/662
CPC
A61K31/00; A61K31/135; A61K31/439; A61K49/0008; A61K31/517; A61K31/662; A61K31/4535; A61P27/16
Inventors
GUITTON, MATTHIEU; PUEL, JEAN-LUC